142
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Therapeutic concentrations of sulfasalazine interfere with ammonia, but not with alanine-aminotransferase determination in enzymatic tests

&
Pages 181-182 | Received 25 Nov 2015, Accepted 30 Nov 2015, Published online: 15 Jan 2016

References

  • Urgent Field Safety Notice. Clin Chem fully automated. FSN-RPD-2015-011, Version 4, June 2015.
  • Schröder H, Campbell DE. Absorption, metabolism, and excretion of salicylazosulfapyridine in man. Clin Pharmacol Ther 1972;13:539–51.
  • Azadkhan AK, Truelove SC, Aronson JK. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol 1982;13:523–8.
  • CLSI. Interference Testing in Clinical Chemistry; Approved Guideline - Second Edition. CLSI document EP07-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
  • Westgard QC. Desirable Biological Variation Database Specifications. Available at: http://www.Westgard.com/biodatabase1.htm. Accessed: September 2015.
  • Ucar F, Erden G, Ozdemir S, Ozcan N, Bulut E, Ozturk A. First data on the biological variation and quality specifications for plasma ammonia concentrations in healthy subjects. Clin Chem Lab Med. 2015; doi: 10.1515/cclm-2015-0591.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.